We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $434M
1-Year Est. Return 9.09%
This Fund
S&P 500
This Quarter Est. Return
+8.84%
1 Year Est. Return
+9.09%
3 Year Est. Return
+56.86%
5 Year Est. Return
+84.63%
10 Year Est. Return
+238.52%
AUM
$806M
AUM Growth
+$39.4M
Cap. Flow
-$29.8M
Cap. Flow %
-3.69%
Top 10 Hldgs %
34.27%
Holding
91
New
6
Increased
24
Reduced
39
Closed
2

Top Sells

Rank Stock Value
1
CAH icon
Cardinal Health
CAH
+$24.9M
2
DVN icon
Devon Energy
DVN
+$9.55M
3
ORCL icon
Oracle
ORCL
+$9.36M
4
R icon
Ryder
R
+$8.92M
5
MSFT icon
Microsoft
MSFT
+$8.45M

Sector Composition

Rank Sector Weight
1 Healthcare 21.04%
2 Technology 15.29%
3 Financials 14.55%
4 Energy 11.39%
5 Consumer Staples 10.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BHI
1
DELISTED
Baker Hughes
BHI
$33.6M 4.17%
608,151
-4,224
-0.7% -$231K
TEVA icon
2
Teva Pharmaceuticals
TEVA
$36.3B
$33.5M 4.16%
835,999
+55,415
+7% +$2.18M
CAG icon
3
Conagra Brands
CAG
$6.88B
$33.3M 4.14%
1,270,970
+423,920
+50% +$10.6M
BG icon
4
Bunge Global
BG
$23.7B
$28.7M 3.57%
349,849
-21,821
-6% -$1.76M
PNC icon
5
PNC Financial Services
PNC
$99.5B
$28.1M 3.49%
362,326
+19,975
+6% +$1.5M
FCX icon
6
Freeport-McMoran
FCX
$91.3B
$26.1M 3.25%
692,782
-100,376
-13% -$3.56M
APA icon
7
APA Corp
APA
$12.9B
$24.4M 3.03%
284,220
-1,883
-0.7% -$168K
MET icon
8
MetLife
MET
$59.5B
$24M 2.98%
499,695
-27,435
-5% -$1.23M
CHKP icon
9
Check Point Software Technologies
CHKP
$13.1B
$22.6M 2.8%
349,811
-33,677
-9% -$2.03M
MSFT icon
10
Microsoft
MSFT
$2.83T
$21.6M 2.69%
577,988
-232,683
-29% -$8.45M
R icon
11
Ryder
R
$10.4B
$20.6M 2.56%
279,817
-134,651
-32% -$8.92M
MOS icon
12
The Mosaic Company
MOS
$7.08B
$20M 2.49%
423,981
-1,753
-0.4% -$81.3K
COV
13
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$18.6M 2.31%
273,410
-12,283
-4% -$799K
MDT icon
14
Medtronic
MDT
$105B
$18.2M 2.26%
316,987
-4,696
-1% -$266K
WBA
15
DELISTED
Walgreens Boots Alliance
WBA
$18.1M 2.25%
315,640
-11,640
-4% -$677K
BAX icon
16
Baxter International
BAX
$11.2B
$18M 2.24%
+476,710
New +$17.3M
AVT icon
17
Avnet
AVT
$7.38B
$17.4M 2.16%
395,336
-17,994
-4% -$742K
PPL
18
PPL Corp
PPL
$27.3B
$17.4M 2.16%
620,951
-64,580
-9% -$1.82M
JBL icon
19
Jabil
JBL
$33.7B
$17.1M 2.13%
982,868
+291,538
+42% +$5.91M
JNJ icon
20
Johnson & Johnson
JNJ
$624B
$16M 1.98%
174,310
-29,777
-15% -$2.74M
RGA icon
21
Reinsurance Group of America
RGA
$15.3B
$14.5M 1.8%
186,956
-2,149
-1% -$156K
DBD
22
DELISTED
Diebold Nixdorf Incorporated
DBD
$13.9M 1.73%
422,268
-17,670
-4% -$551K
MRK icon
23
Merck
MRK
$322B
$13.9M 1.73%
291,123
+29,239
+11% +$1.34M
NSC icon
24
Norfolk Southern
NSC
$78.3B
$12.7M 1.57%
136,462
-23,450
-15% -$2.01M
TUP
25
DELISTED
Tupperware Brands Corporation
TUP
$11.5M 1.43%
122,106
-6,530
-5% -$593K

Similar funds

Foyston, Gordon, & Payne's Q4 2013 Portfolio in Review

As of Q4 2013, Foyston, Gordon, & Payne held 91 positions worth $806M, up 5.1% from $766M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Foyston, Gordon, & Payne withdrew a net $29.8M in Q4 2013, closing 2 positions and reducing 39 holdings. Its most notable exit was Unilever, an estimated $3.57M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Technology and Financials.

Against the trend, Foyston, Gordon, & Payne opened a new position in Baxter International worth $18M.

  • Foyston, Gordon, & Payne's largest Q4 2013 buy was Baxter International: 476,710 shares worth $18M.
  • Foyston, Gordon, & Payne added most to Conagra Brands in Q4 2013, an estimated $10.6M increase.
  • Foyston, Gordon, & Payne's biggest Q4 2013 reduction was Cardinal Health, cutting an estimated $24.9M.
  • Foyston, Gordon, & Payne fully exited Unilever in Q4 2013, selling an estimated $3.57M.
  • Foyston, Gordon, & Payne's ten largest holdings make up 34% of its $806M portfolio in Q4 2013.
  • Foyston, Gordon, & Payne opened 6 new positions and closed 2 in Q4 2013.
  • Foyston, Gordon, & Payne's portfolio value rose 5.1% quarter-over-quarter to $806M.

Based on Foyston, Gordon, & Payne's 13F filing for Q4 2013, filed 13 Feb 2014.